Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/2009
05/14/2009WO2008154251A3 C3b antibodies and methods for the prevention and treatment of complement- associated disorders
05/14/2009WO2008074803A8 4-benzyl-l ( 2h) -phthalazinones as h1 receptor antagonists
05/14/2009WO2008068540A8 New benzamide derivatives as bradykinin antagonists
05/14/2009WO2008060626A3 Compounds for modulating trpv3 function
05/14/2009WO2008041236A3 Composition comprising crustacean gastrolith components, calcium carbonate and its use
05/14/2009US20090124686 Gsk-3 inhibitors
05/14/2009US20090124681 Beta-lactone compounds
05/14/2009US20090124674 Method for treating congestive heart failure
05/14/2009US20090124673 Method for treating diabetic nephropathy
05/14/2009US20090124671 Trpv1 antagonists
05/14/2009US20090124667 Novel Dual-Use Peptidase Inhibitors as Prodrugs for a Therapy of Inflammatory and Other Diseases
05/14/2009US20090124635 Chemical compounds
05/14/2009US20090124625 Novel alkynyl derivatives as modulators of metatropic glutamate receptors
05/14/2009US20090124607 Novel Bicyclic Sulfonamides for Use as Glucocorticoid Receptor Modulators in the Treatment of Inflammatory Diseases
05/14/2009US20090124573 Immunomodulating compounds and related compositions and methods
05/14/2009US20090124555 Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents
05/14/2009US20090124554 Buccal, polar and non-polar spray or capsule containing drugs for treating pain
05/14/2009US20090123938 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist
05/14/2009US20090123565 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
05/14/2009US20090123558 Polarized Scorpion Venom Solution and a Method for Making Polarized Scorpion Venom Solution
05/14/2009US20090123551 Gastrointestinal delivery systems
05/14/2009US20090123550 Corticosteroid compositions
05/14/2009US20090123530 Liposome Drug Delivery
05/14/2009US20090123508 Implantable Drug Depot for Intrathecal Drug Delivery System for Pain Management
05/14/2009US20090123504 Olive oil formulation for pain relief
05/14/2009US20090123479 Immunoglobulins
05/14/2009US20090123454 using collagenase injections to lyse the collagenous adhesions in the shoulder and treat adhesive capsulitis or frozen shoulder
05/14/2009CA2713394A1 Anti-inflammatory quinic acid derivatives for oral administration
05/14/2009CA2704684A1 Compounds which modulate the cb2 receptor
05/14/2009CA2704380A1 Avenanthramide-containing compositions
05/14/2009CA2703987A1 Cyclobutyl carboxylic acid derivatives
05/13/2009EP2058333A2 Anti-CCR2 antibodies and methods of use therefor
05/13/2009EP2058317A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient
05/13/2009EP2058310A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor comprising the derivative
05/13/2009EP2058309A1 Fused heterocyclic compound
05/13/2009EP2057993A1 Method for production of hop preparation, hop preparation, antiinflammatory agent, food/beverage, and oral product
05/13/2009EP2057164A1 Triazolotriazines as kinase inhibitors
05/13/2009EP2057158A1 Triazole derivatives as kinase inhibitors
05/13/2009EP2057148A1 Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents
05/13/2009EP2057139A1 Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
05/13/2009EP2057122A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the 2 adrenergic receptor
05/13/2009EP2057116A1 New phenylsulfamoyl benzamide derivatives as bradykinin antagonists
05/13/2009EP2057115A1 4-substituted phenoxyphenylacetic acid derivatives
05/13/2009EP2056857A2 Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation
05/13/2009EP1721610B1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative
05/13/2009EP1397356B1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1)
05/13/2009EP1317536B1 Tnf receptor-like molecules and uses thereof
05/13/2009EP1165807B1 A protease, a gene therefor and the use thereof
05/13/2009EP1115743B1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
05/13/2009EP1062209B1 Metabolically inert anti-inflammatory and anti-tumor antifolates
05/13/2009CN101432264A Salts with CRTH2 antagonist activity
05/13/2009CN101431999A Use of VX-702 for treating rheumatoid arthritis
05/13/2009CN101431990A Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and paracetamol
05/13/2009CN101429185A Two-crystal type of substance of meletin, production method, medicament composition and uses thereof
05/13/2009CN101429184A Two-crystal type of substance of luteolin, production method, medicament composition and uses thereof
05/13/2009CN101429181A P-hydroxybenzene acrylic acid derivative and uses thereof
05/13/2009CN101428138A Uses of Chilobrachys jingzhao toxin extract-jingzhao toxin-V in preparing pain easing medicament
05/13/2009CN101428134A Process for producing four-Tibet inula root soft capsule
05/13/2009CN101428126A Externally used medicinal liquor for massaging spondyle
05/13/2009CN101428121A Traditional Chinese medicine liniment for activating blood circulation and removing stasis, dispersing the swelling, relieving pain, relaxing tendons and activating collaterals
05/13/2009CN101428105A Method of preparing medicine for quickly resolving stagnation
05/13/2009CN101428076A Process for producing cassia twig tuckahoe formulation
05/13/2009CN101428074A Natural Chinese medicinal herb plaster
05/13/2009CN101428073A Method of preparing plaster for quickly releasing leg pain
05/13/2009CN101428052A Method for extracting radix gynurae segeti alkaloid with supercritical carbonic anhydride
05/13/2009CN101428049A Upper respiratory tract infection resistant medicament composition, preparation and uses thereof
05/13/2009CN101428048A Uses of isatis root GAP medicinal materials extract in preparing antiendotoxin febrifuge medicament
05/13/2009CN101428046A Novel broad spectrum antiphlogistic pain-easing externally used medicament
05/13/2009CN101428031A Medicament preparation for preventing cardiovascular diseases
05/13/2009CN101428016A Uses of di-indole methyl hydride and its derivant in treating rheumatoid arthritis
05/13/2009CN100487450C Preparation medicine of wind dispelling pain eliminating tablet and its preparation methid, quality control method
05/13/2009CN100486996C Antibodies to human MCP-1
05/13/2009CN100486985C 9a-azalides with anti-inflammatory activity
05/13/2009CN100486646C Polyethylene glycol-phosphatidyl ethanolamine polymer or medicinal acid addition salt and application thereof in pharmacy
05/13/2009CN100486643C Pharmaceutical oral dosage form comprising a non-steroidal anti-inflammatory drug, and having good palatability
05/13/2009CN100486641C Compound bone peptide medicine composition oral preparation and preparation method therefor
05/13/2009CN100486614C Medication for treating disease of proplapse of lumbar intervertebral disc
05/13/2009CN100486605C Big bitter gourd in application for preparing medication
05/13/2009CN100486597C A pharmaceutical composition made from Chinese traditional medicine for treating snuffle, headache and preparation method thereof
05/13/2009CN100486576C Substituted pyridinones as modulators of P38MAP kinase
05/13/2009CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use
05/13/2009CN100486568C Loxoprofen sodium sustained release preparation
05/12/2009US7531651 e.g. 4-({[({[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}amino)carbonyl]amino}methyl)benzamide benzenesulfonate dihydrate; chemokine (C-C motif) receptor antagonist; antiinflammatory agent; asthma, rhinitis
05/12/2009US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation
05/12/2009US7531564 Substituted benzoxazoles as estrogenic agents
05/12/2009US7531549 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
05/12/2009US7531546 inhibitors of cysteine proteases; neuropathic pain, inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis, tumors, obesity, coronary disease, atherosclerosis; 6-(2-Acetyl-2,8-diaza-spiro[4.5]dec-8-ylmethyl)-7-(2-cyclohexyl-ethyl)-7H-pyrrolo[2,3d]pyrimidine-2-carbonitrile
05/12/2009US7531540 phosphodiesterase type 4 inhibitors; to treat respiratory disorders, skin disorders like psoriasis and atopic eczema; low toxicity, high bioavailability, no significant side effects; 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-acetamide
05/12/2009US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
05/12/2009US7531527 (20R)-1 alpha ,25-dihydroxy-2-[3'-hydroxypropylidene]-19-norvitamin D3; high intestinal calcium transport activity; ability to mobilize calcium from bone; bone replacement surgeries, autoimmune diseases, multiple sclerosis, diabetes mellitus,lupus, antiproliferative agents
05/12/2009US7531526 Boronic ester and acid compounds, synthesis and uses
05/12/2009US7531516 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis
05/12/2009US7531175 Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules
05/12/2009CA2419178C Cytokine production inhibitor
05/12/2009CA2387398C Novel combination of loteprednol and antihistamines
05/12/2009CA2386404C Method of treating inflammatory conditions with progesterone or progesterone analogs
05/12/2009CA2377301C Controlled release and taste masking oral pharmaceutical compositions
05/12/2009CA2356080C Improved formulation for transportation of corticosteroid through pores of a barrier
05/12/2009CA2322027C Use of macrolide compounds for the treatment of ards
05/12/2009CA2264005C Piperazino derivatives as neurokinin antagonists